ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Final results of a phase II trial of R-IDEA as salvage therapy in patients with relapsed/refractory diffuse large B-cell lymphoma
Annals of Oncology
◽
10.1093/annonc/mdw375.26
◽
2016
◽
Vol 27
◽
pp. vi321
Author(s):
E. Kondo
◽
K. Yamamoto
◽
T. Masunari
◽
J. Takizawa
◽
K. Miura
◽
...
Keyword(s):
B Cell
◽
Phase Ii
◽
Salvage Therapy
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Related Documents
Cited By
References
831MO Geptanolimab in Chinese patients with relapsed or refractory primary mediastinal large B-cell lymphoma: Results from a multicenter, open-label, single-arm phase II trial
Annals of Oncology
◽
10.1016/j.annonc.2021.08.124
◽
2021
◽
Vol 32
◽
pp. S775-S776
Author(s):
Y-K. Shi
◽
J. Cui
◽
H. Zhou
◽
X. Zhang
◽
L.Q. Zou
◽
...
Keyword(s):
B Cell
◽
Phase Ii
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Chinese Patients
◽
Open Label
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Updated results of a phase II trial of brentuximab vedotin combined with R-CHOP in frontline treatment of patients (pts) with high-intermediate/high-risk diffuse large B-cell lymphoma (DLBCL).
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.8506
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. 8506-8506
◽
Cited By ~ 3
Author(s):
Nancy L. Bartlett
◽
Charles M. Farber
◽
Christopher A. Yasenchak
◽
Stephen Maxted Ansell
◽
Ranjana H. Advani
◽
...
Keyword(s):
High Risk
◽
B Cell
◽
Phase Ii
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Brentuximab Vedotin
◽
Large B Cell Lymphoma
◽
Frontline Treatment
◽
Large B Cell
Download Full-text
A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma
British Journal of Haematology
◽
10.1111/bjh.14232
◽
2016
◽
Vol 175
(2)
◽
pp. 281-289
◽
Cited By ~ 32
Author(s):
Steven I. Park
◽
Natalie S. Grover
◽
Oludamilola Olajide
◽
Adam S. Asch
◽
James G. Wall
◽
...
Keyword(s):
B Cell
◽
Phase Ii
◽
Older Patients
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
Clinical Lymphoma Myeloma & Leukemia
◽
10.1016/j.clml.2018.05.023
◽
2018
◽
Vol 18
(9)
◽
pp. 569-575.e1
◽
Cited By ~ 15
Author(s):
Victor Yazbeck
◽
Danielle Shafer
◽
Edward B. Perkins
◽
Domenico Coppola
◽
Lubomir Sokol
◽
...
Keyword(s):
B Cell
◽
Mantle Cell Lymphoma
◽
Phase Ii
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Large B Cell Lymphoma
◽
Mantle Cell
◽
Large B Cell
Download Full-text
A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma
British Journal of Haematology
◽
10.1111/bjh.12537
◽
2013
◽
Vol 163
(3)
◽
pp. 334-342
◽
Cited By ~ 32
Author(s):
Bertrand Coiffier
◽
John Radford
◽
André Bosly
◽
Giovanni Martinelli
◽
Gabriela Barca
◽
...
Keyword(s):
B Cell
◽
Phase Ii
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Multicentre Phase
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi
Hematological Oncology
◽
10.1002/hon.2425
◽
2017
◽
Vol 36
(1)
◽
pp. 68-75
◽
Cited By ~ 13
Author(s):
Stefano Luminari
◽
Elda Viel
◽
Andrés José Maria Ferreri
◽
Francesco Zaja
◽
Emanuela Chimienti
◽
...
Keyword(s):
B Cell
◽
Phase Ii
◽
Liposomal Doxorubicin
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Combination Regimen
◽
Large B Cell Lymphoma
◽
Large B Cell
◽
Cardiac Comorbidity
Download Full-text
Idelalisib in relapsed/refractory diffuse large B‐cell lymphoma: results from a Nordic Lymphoma Group phase II trial
British Journal of Haematology
◽
10.1111/bjh.17792
◽
2021
◽
Author(s):
Karin Fjordén
◽
Sara Ekberg
◽
Nevzeta Kuric
◽
Karin E. Smedby
◽
Ingemar Lagerlöf
◽
...
Keyword(s):
B Cell
◽
Phase Ii
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor
Value in Health
◽
10.1016/j.jval.2020.08.462
◽
2020
◽
Vol 23
◽
pp. S479-S480
Author(s):
R.O. Casasnovas
◽
P. Daniele
◽
G. Tremblay
◽
M. Maerevoet
◽
J. Zijlstra
◽
...
Keyword(s):
B Cell
◽
Phase Ii
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Health Utility
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B-cell lymphoma: a phase-II trial by the Hellenic Cooperative Oncology Group
European Journal Of Haematology
◽
10.1111/j.1600-0609.2005.00482.x
◽
2005
◽
Vol 75
(2)
◽
pp. 124-129
◽
Cited By ~ 17
Author(s):
Efstathios S. Papageorgiou
◽
Panagiotis Tsirigotis
◽
Meletios Dimopoulos
◽
Nikolaos Pavlidis
◽
George Fountzilas
◽
...
Keyword(s):
B Cell
◽
Phase Ii
◽
Combination Chemotherapy
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Oncology Group
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Faculty Opinions recommendation of A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1109420.565473
◽
2008
◽
Author(s):
Noel Milpied
Keyword(s):
B Cell
◽
Phase Ii
◽
Phase Ii Trial
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Chop Chemotherapy
◽
Ibritumomab Tiuxetan
◽
Large B Cell Lymphoma
◽
Large B Cell
◽
Yttrium 90
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close